Modified red blood cell products may be better at counteracting anemia than red blood cell suspensions normally used in conventional…
Articles by Joana Carvalho, PhD
Physicians should consider testing patients with COVID-19 and thrombosis for different forms of autoimmune hemolytic anemia (AIHA),…
The presence of cold agglutinin disease (CAD) without red blood cells’ destruction in patients with COVID-19 should prompt…
The prevalence of cold agglutinin disease (CAD) is four times higher in colder climates than in warmer areas, according…
Treatment with rituximab is safe and effective in managing autoimmune hemolytic anemia (AIHA), and seems to be…
Heart surgery can be performed safely in people with cold agglutinin disease (CAD) by adopting a series of procedure…
People with cold agglutinin disease (CAD) have genetic alterations previously reported in patients with marginal zone lymphoma (MZL),…
Physicians have described the rare case of a woman with cold agglutinin disease (CAD) associated with advanced breast…
T follicular helper cells, a subset of T-cells that help other immune cells produce antibodies, seem to play a role…
New targeted therapy options are needed for patients who develop autoimmune hemolytic anemia (AIHA) following a stem cell transplant, a…